Abound Wealth Management Trans Medics Group, Inc. Transaction History
Abound Wealth Management
- $312 Billion
- Q4 2024
A detailed history of Abound Wealth Management transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Abound Wealth Management holds 2 shares of TMDX stock, worth $143. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2Holding current value
$143% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TMDX
# of Institutions
345Shares Held
30.5MCall Options Held
671KPut Options Held
858K-
Vanguard Group Inc Valley Forge, PA3.64MShares$262 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$190 Million0.01% of portfolio
-
State Street Corp Boston, MA1.36MShares$97.9 Million0.0% of portfolio
-
Fil LTD Hamilton, D01MShares$72 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3993KShares$71.4 Million0.07% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $2.29B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...